Embium Successfully Raises Another Round of Funding

TORONTO, Nov. 12, 2013 /CNW/ - Embium, a Canadian provider of automated trading technology for global financial firms, today announced another significant round of funding from two high profile investors. It was requested that the amount not be disclosed.

The funding will serve to accelerate the development of Embium's technology offering and product suite. Furthermore, it will provide the necessary resources to continue to build out a team of highly talented professionals, with significant experience and insight from the financial industry.

Janice Robson, Chief Executive Officer, Embium said "We are thrilled to have such strong support from our investors, who believe in both our technology and the team behind it. Their extensive experience in this industry has been invaluable in providing Embium with the appropriate strategic direction and vision to successfully compete on a global scale."

About Embium

Embium is a leading provider of multi-asset (equities, options, futures and FX), broker neutral automated trading solutions for global financial firms. Embium offers a rich product suite that includes an algorithm development environment; real-time simulation and backtesting; in-memory complex event processing; real-time risk management; and a secure co-located trading infrastructure. Embium is headquartered in Waterloo, Ontario, Canada with offices in Toronto and New York.

SOURCE: Embium

For further information:

For more information, please visit the Embium website at www.embium.com or send an email to sales@embium.com

Profil de l'entreprise

Embium

Renseignements sur cet organisme


FORFAITS PERSONNALISÉS

Jetez un coup d’œil sur nos forfaits personnalisés ou créez le vôtre selon vos besoins de communication particuliers.

Commencez dès aujourd'hui .

ADHÉSION À CNW

Remplissez un formulaire d'adhésion à CNW ou communiquez avec nous au 1-877-269-7890.

RENSEIGNEZ-VOUS SUR LES SERVICES DE CNW

Demandez plus d'informations sur les produits et services de CNW ou communiquez avec nous au 1‑877-269-7890.